Additionally, some studies on the effects of metformin have shown potential benefits through uteroglobin in prostate cancer and prostate-related disease such as benign prostatic hyperplasia and prostatitis (53, 54). The gene discussed is SCGB1A1; the disease is male reproductive organ cancer.